Discovery and functional characterization of a germline, CSF2RB-activating mutation in leukemia.
Cancer Biology Program, Oregon Health & Science University, Knight Cancer Institute, Portland, OR, USA.
K
K
Watanabe-Smith
Division of Hematology and Medical Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, OR, USA.|Howard Hughes Medical Institute, Portland, OR, USA.
C
C
Tognon
Department of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Knight Cancer Institute, Portland, OR, USA.
J W
JW
Tyner
Department of Pediatric Oncology, Erasmus University Medical Center, Sophia Children's Hospital, Rotterdam, The Netherlands.
J P P
JP
Meijerink
Division of Hematology and Medical Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, OR, USA.|Howard Hughes Medical Institute, Portland, OR, USA.
B J
BJ
Druker
Division of Hematology and Medical Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, OR, USA.|Department of Molecular & Medical Genetics, Oregon Health & Science University, Portland, OR, USA.
A
A
Agarwal
D002648:Child; D053648:Cytokine Receptor Common beta Subunit / Q000235:genetics*; D018095:Germ-Line Mutation; D006801:Humans; D054218:Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics*
C115876:CSF2RB protein, human; D053648:Cytokine Receptor Common beta Subunit